Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bayard Delafield Clarkson Jr., M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R13CA040577 (FOTI, MARGARET) Mar 15, 1985 - Aug 31, 2021
    Young Minority Scientists in the Field of Cancer
    Role: Co-Principal Investigator
  2. P01CA020194 (CLARKSON, BAYARD D) Jan 1, 1984 - Dec 31, 1992
    Role: Principal Investigator
  3. P01CA005826 (SPRIGGS, DAVID R) Jan 1, 1978 - Jun 30, 2007
    Role: Co-Principal Investigator
  4. T32CA009207 (BAJORIN, DEAN F.) Sep 30, 1977 - Aug 31, 2024
    Investigational Cancer Therapeutics Training Program
    Role: Co-Principal Investigator
  5. R01CA019117 (CLARKSON, BAYARD D) Jun 30, 1976 - Dec 31, 1987
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Guo T, Hajdu M, Agaram NP, Shinoda H, Veach D, Clarkson BD, Maki RG, Singer S, Dematteo RP, Besmer P, Antonescu CR. Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502-3ins mutation: an in vitro mutagenesis screen for drug resistance. Clin Cancer Res. 2009 Nov 15; 15(22):6862-70. PMID: 19861442.
    Citations: 36     Fields:    Translation:HumansAnimalsCells
  2. Guo T, Agaram NP, Wong GC, Hom G, D'Adamo D, Maki RG, Schwartz GK, Veach D, Clarkson BD, Singer S, DeMatteo RP, Besmer P, Antonescu CR. Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor. Clin Cancer Res. 2007 Aug 15; 13(16):4874-81. PMID: 17699867.
    Citations: 53     Fields:    Translation:HumansAnimalsCells
  3. Antonescu CR, Busam KJ, Francone TD, Wong GC, Guo T, Agaram NP, Besmer P, Jungbluth A, Gimbel M, Chen CT, Veach D, Clarkson BD, Paty PB, Weiser MR. L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. Int J Cancer. 2007 Jul 15; 121(2):257-64. PMID: 17372901.
    Citations: 73     Fields:    Translation:HumansAnimalsCells
  4. Azam M, Nardi V, Shakespeare WC, Metcalf CA, Bohacek RS, Wang Y, Sundaramoorthi R, Sliz P, Veach DR, Bornmann WG, Clarkson B, Dalgarno DC, Sawyer TK, Daley GQ. Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance. Proc Natl Acad Sci U S A. 2006 Jun 13; 103(24):9244-9. PMID: 16754879.
    Citations: 29     Fields:    Translation:HumansCells
  5. Clarkson B, Chabner BA, Weinberg RA. Targets for specific therapies in leukemia. Cancer Res. 1995 Oct 01; 55(19):4488-98. PMID: 7545542.
    Citations:    Fields:    Translation:Humans
  6. Berman E, Duigou-Osterndorf R, Krown SE, Fanucchi MP, Chou J, Hirsch MS, Clarkson BD, Chou TC. Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells. Blood. 1989 Sep; 74(4):1281-6. PMID: 2765664.
    Citations: 6     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Clarkson's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (71)
Co-Authors (5)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.